Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

The following example illustrates stability study results for an ENDS tobacco product. Stability study results are represented in the Tobacco Product Testing (PT) domain, with PTCAT = STABILITY TESTING.

Info

The first pt.xpt dataset shows 22 consituents and parameters each as a single replicate (PTREPNUM=1), at 1 time point (PTTPT=Week 0 / PTTPTNUM=1) and from 1 set of storage conditions (STOCONID= Condition 1)

Info

NOTE TO TEAM REVIEWERS:

The example below demonstrates the required data structure of one record per analyte per replicate per test condition per timepoint to accurately represent data from a stability study.
The resulting structure would require 648 rows to illustrate the 12 analytes shown in the example study we received, done in triplicate under two test conditions at the number of timepoints in the example study.

For conciseness, we have abbreviated the examples below to demonstrate the concepts as follows:

First- we show all 12 analytes as a single replicate, at one time point and one test condition in order to illustrate the variables and terminology required to put together a stability study with assays  done in replicate at different time points and varying test conditions, even though only one record per analyte is illustrated.

Second- We show ONE analyte (moisture) in triplicate, over a series of time points and two test conditions to give a sense of what the complete data would look like.

Hopefully users could combine the information shown in both examples to construct a complete dataset containing all the records for each analyte-replicate-test condition-time point group.

Info
titleTobacco domains

DI = TO for Tobacco Product Identifiers and Descriptors

SPDEVID = SPTOBID for Sponsor Tobacco Product Identifier

DO/DU = Tobacco Product Design Parameters (PD)

LB = Tobacco Product Testing (PT) - [Would Findings be better?]

Shelf life study has a protocol and provides the results of shelf life studies of Vapes products over time with different conditions and analytes.  Generally there are many conditions with at least two with varying temperature, humidity, etc.

The initial table shows the a number of the analytes and test conditions used in Shelf Life studies for Vapes products for one testing condition at one timepoint and one replicate.

Tobacco Product Testing (TT) is a Findings domain similar to the Laboratory Test Results domain.

construct an SDTM-conformant PT dataset for a stability study. Some constituent names (values of PTTESTCD/PTTEST) appear twice because they are tested separately in both e-liquid and aerosol (as indicated by PTSPEC). Note that the constituent names shown do not represent an exhaustive list of the controlled terminology that will be developed to support representation of stability studies in SDTM.

Note
  • The use of SPDEVID and PTREFID in this example on records where PTSPEC=AEROSOL indicates that a smoking machine (shown in SPDEVID) was used to perform the vaping regimen (shown in PTREFID) to produce the aerosol from the e-liquid product on records where PTSPEC=AEROSOL. Details of the smoking machine and vaping regimen are not shown in this example. For examples illustrating how to represent these concepts in SDTM, see Section 3.1.3.2, HPHCs, Other Constituents, and Smoking / Vaping Regimens.
  • PTXFN (External File Path) is used to document the location or file name within the submission that contains the lab methodology protocol used to assay the associated constituent when such methodology is too complex for the single PTMETHOD variable.
  • STOCONID is used to identify the storage conditions of the e-liquid product for the testing performed. Details of these conditions are represented in the Environmental Storage Conditions (ES) dataset example that follows the 2 PT dataset examples. 
  • In this example, the applicant chose to subcategorize some consituents and parameters using the permissible variable PTSCAT (Sub-Category of Test).
Dataset wrap
Namept
Rowcaps
Rows 1, 3, 5, 7, 9, 10, 15, 17-19, 22, 24, 25, 27-31:Show the results of testing for constituents in samples of e-liquid product (PTSPEC=E-LIQUID).
Rows 2, 4, 6, 8, 11-14, 16, 20, 21, 23, 26:Show the results of testing for constituents/parameters in aerosol produced from the e-liquid product. The smoking machine is shown in SPDEVID and the regimen is shown in PTREFID.
Dataset wrap
Namept
Show microbials used in testing (aerobic plate count, mold, and yeast) using the PTTEST and PTTESTCD variable in the E-Liquid substance for the condition noted in PTTSTCND which is E-Liquid Standard (Long Term) Condition.  
Rowcaps
Row 1-12:Shows several analytes (as noted in the PTTEST) in the E-Liquid substance for the condition noted in PTTSTCND which is E-Liquid Standard (Long Term) Condition. 
Rows 7 - 9:
Dataset2
RowSTUDYIDDOMAIN
PTSEQ
SPTOBID
PTREFID
SPDEVIDSTOCONDIDPTSEQPTREFID
SPTOBID
PTTESTCDPTTESTPTCAT
PTTSTCND
PTSCATPTORRESPTORRESUPTLLODPTSTRESCPTSTRESNPTSTRESU
PTSPEC
PTNAM
PTSPCCND
PTXFN
PTMETHOD
PTSPECPTLLOQPTREPNUMPTDTCPTTPTPTTPTNUM
1TOB07PT111
Condition 1
VAP77777.

1

111NIC


NICOTINENicotineSTABILITY
STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 01
TESTING
35.94mg/g
35.9435.94mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023
2TOB07PT2VAP77777.1111XXXXX

Nicotine Degredants

STABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1
Week 01
3
2TOB07PT111
3
PUFFMASTER3K
VAP77777.
Condition 1
111XXXXXPrimary Ingredients - Gly / PGSTABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1
2NON-INTENSE REGIMENNICOTINENicotineSTABILITY TESTING

0.1039

mg/PUFF
0.10390.1039mg/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
4
3TOB07PT
4
111
VAP77777.

Condition 1
111
3
XXXXXOrganic compounds - i.e. acids or RXN

NORNCTN

Nornicotine

STABILITY
STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 01
TESTINGNicotine Degradant25.76ug/g
25.7625.76ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023
5TOB07PT6VAP77777.1111CHARFLAVFlavorant - is this the same as Characterizing Flavor?STABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1
Week 01
6
4TOB07PT
8
111PUFFMASTER3KCondition
VAP77777.
1
111XXXXXHPHCSTABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 01
4NON-INTENSE REGIMENNORNCTN

Nornicotine

STABILITY TESTINGNicotine Degradant0.0392ug/PUFF
0.03920.0392ug/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
5TOB07PT111
Condition 15
GLYCRLGlycerolSTABILITY TESTINGPrimary Ingredient615.68mg/g
615.68615.68mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023
7TOB07PT10VAP77777.1111XXXXXExtractables / Leachables STABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 018TOB07PT11VAP77777.1111XXXXXNon targeted compoundsSTABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1
Week 01
9
6TOB07PT111
12
PUFFMASTER3K
VAP77777.
Condition 1
111XXXXXPotential Combustion ProductsSTABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 0110TOB07PT12VAP77777.1111XXXXXCigarette ReferenceSTABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1
6NON-INTENSE REGIMENGLYCRLGlycerolSTABILITY TESTINGPrimary Ingredient1.81mg/PUFF0.001441.811.81mg/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023
Week 01
11
7TOB07PT
12
111
VAP77777.

Condition 1
111
7
XXXXX

PRPYLGLY
Aerosol MassSTABILITY STUDYE-Liquid Standard (Long Term) Condition
Propylene GlycolSTABILITY TESTINGPrimary Ingredient218.21mg/g
218.21218.21mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID
1
Week 1
0.0011
12TOB07PT12VAP77777.1111PHpHSTABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID
02-01-2023Week 01
13
8TOB07PT111
12
PUFFMASTER3K
VAP77777.
Condition 1
111XXXXXmicrobiologicalSTABILITY STUDYE-Liquid Standard (Long Term) ConditionE-LIQUID1Week 01

*DWB=Dry weight basis. The DWB normalizes the results since starting moisture may vary.

A Shelf Life study dataset would shows analytes done in different test conditions with replicates over time points.  In the interest of brevity for this example, only portions of the content using the TEST of Nicotine is shown in a sample of timepoints in two conditions with replicates. The weeks reflective of Week 1,  Week 2, Week 3, etc. which would align with the PTTPTNUM of 2,3, etc. are not shown for visual viewing purposes.

8NON-INTENSE REGIMENPRPYLGLYPropylene GlycolSTABILITY TESTINGPrimary Ingredient0.8565mg/PUFF0.000240.85650.8565mg/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
9TOB07PT111
Condition 19
BNZOICACBenzoic AcidSTABILITY TESTINGAcid42.2ug/PUFF
42.242.2ug/PUFFTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
10TOB07PT111
Condition 110
MENTHOLMentholSTABILITY TESTINGFlavorant37.53mg/g
37.5337.53mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
11TOB07PT111PUFFMASTER3KCondition 111NON-INTENSE REGIMENMENTHOLMentholSTABILITY TESTINGFlavorant0.5881mg/PUFF0.000240.58810.5881mg/PUFFTPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023Week 01
12TOB07PT111PUFFMASTER3KCondition 112NON-INTENSE REGIMENGLYCDOLGlycidolSTABILITY TESTINGStabilizerNOT DETECTED
0.00011NOT DETECTED

TPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023Week 01
13TOB07PT111PUFFMASTER3KCondition 113NON-INTENSE REGIMENFRMLDHDFormaldehydeSTABILITY TESTING
0.0728ug/PUFF0.005490.07280.0728ug/PUFFTPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023Week 01
14TOB07PT111PUFFMASTER3KCondition 114NON-INTENSE REGIMENACROLNAcrolienSTABILITY TESTING
DETECTED, BELOW LLOQ
0.00928DETECTED, BELOW LLOQ

TPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023Week 01
15TOB07PT111
Condition 115
LACTICACLactic AcidSTABILITY TESTING
40.44ug/g
40.4440.44ug/gTPT LABCOTLEL01_v1.5.pdf

E-LIQUID

0.001102-01-2023Week 01
16TOB07PT111PUFFMASTER3KCondition 116NON-INTENSE REGIMENLACTICACLactic AcidSTABILITY TESTING
29.71ug/PUFF0.28429.7129.71ug/PUFFTPT LABCOTLAE01_v2.1.pdf

AEROSOL

0.001102-01-2023Week 01
17TOB07PT111
Condition 117
VANLLNVanillinSTABILITY TESTINGFlavorant1.12ug/g
1.121.12ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
18TOB07PT111
Condition 118
NNKNicotine-Derived Nitrosamine KetoneSTABILITY TESTINGHPHC0.0711ug/g
0.07110.0711ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
19TOB07PT111
Condition 119
NNNN-NitrosonornicotineSTABILITY TESTINGHPHC0.0852ug/g
0.08520.0852ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
20TOB07PT111PUFFMASTER3KCondition 120NON-INTENSE REGIMENNNKNicotine-Derived Nitrosamine KetoneSTABILITY TESTINGHPHC0.0577ug/PUFF
0.05770.0577ug/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
21TOB07PT111PUFFMASTER3KCondition 121NON-INTENSE REGIMENNNNN-NitrosonornicotineSTABILITY TESTINGHPHC0.0742ug/PUFF
0.07420.0742ug/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
22TOB07PT111
Condition 122
NICKELNickelSTABILITY TESTINGExtractables / Leachables0.0897ug/g
0.08970.0897ug/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
23TOB07PT111PUFFMASTER3KCondition 123NON-INTENSE REGIMENMASSMassSTABILITY TESTING
3.87mg/PUFF0.00713.873.87mg/PUFFTPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
24TOB07PT111
Condition 124
CHROMIUMChromiumSTABILITY TESTING
NOT DETECTED

NOT DETECTED

TPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
25TOB07PT111
Condition 125
PH

pH

STABILITY TESTING
7.15

7.157.15
TPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
26TOB07PT111PUFFMASTER3KCondition 126NON-INTENSE REGIMENPHpHSTABILITY TESTING
7.24

7.247.24
TPT LABCOTLAE01_v2.1.pdfAEROSOL0.001102-01-2023Week 01
27TOB07PT111
Condition 127
ENDTXNEndotoxinSTABILITY TESTINGToxinsNOT DETECTED

NOT DETECTED

TPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
28TOB07PT111
Condition 128
AEBCTAerobic Colony CountSTABILITY TESTINGMicrobiological<1CFU/mL
<1
CFU/mLTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
29TOB07PT111
Condition 129
YSTMLDCTYeast and/or Mold Colony CountSTABILITY TESTINGMicrobiological1CFU/mL
11CFU/mLTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
30TOB07PT111
Condition 130
ACTALDAcetaldehydeSTABILITY TESTINGAldehyde7.8ug/mL
7.87.8ug/mLTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
31TOB07PT111
Condition 131
ACTPROPNAcetyl PropionylSTABILITY TESTINGDiketone32.4ug/mL
32.432.4ug/mLTPT LABCOTLEL01_v1.5.pdfE-LIQUID0.001102-01-2023Week 01
Info

The second PT dataset shows testing for just 1 constituent (nicotine), performed in 3 replicates (note the values of PTREPNUM), at the first 3 time points of the study (as shown in PTTPT/PTTPTNUM), from 3 sets of storage conditions (STOCONID), in samples of e-liquid and aerosol (PTSPEC) in order to illustrate how those variables are used to represent their associated concepts in a stability study. 

Note
  • As in the first PT dataset, the details of the smoking machine and vaping regimen are not shown in this example. For examples illustrating how to represent these concepts in SDTM, see Section 3.1.3.2, HPHCs, Other Constituents, and Smoking/Vaping Regimens.
  • Details of the 3 conditions are represented in the ES dataset example that follows.
Dataset wrap
Namept
Dataset2
Row

STUDYID

DOMAINSPTOBIDSPDEVIDSTOCONIDPTSEQPTREFIDPTTESTCDPTTESTPTORRESPTORRESUPTSTRESCPTSTRESNPTSTRESUPTNAMPTXFNPTSPECPTREPNUMPTDTCPTTPTPTTPTNUM
1TOB07PT111
Condition 1211
NICOTINE

Nicotine

35.94mg/g35.9435.94mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID102-01-2023Week 01
2TOB07PT111
Condition 1212


NICOTINE

Nicotine35.46mg/g35.4635.46mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID202-01-2023Week 01
3TOB07PT111
Condition 1213
NICOTINENicotine35.97mg/g35.9735.97mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID302-01-2023Week 01
4TOB07PT111
Condition 1214
NICOTINENicotine35.55mg/g35.5535.55mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID103-29-2023Week 82
5TOB07PT111
Condition 1215
NICOTINENicotine35.88mg/g35.8835.88mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID203-29-2023Week 82
6TOB07PT111
Condition 1216
NICOTINENicotine35.67mg/g35.6735.67mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID303-29-2023Week 82
7TOB07PT111
Condition 1217
NICOTINENicotine36.11mg/g36.1136.11mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID107-19-2023Week 243
8TOB07PT111
Condition 1218
NICOTINENicotine35.72mg/g35.7235.72mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID207-19-2023Week 243
9TOB07PT111
Condition 1219
NICOTINENicotine35.54mg/g35.5435.54mg/gTPT LABCOTLEL01_v1.5.pdfE-LIQUID307-19-2023Week 243
10TOB07PT111PUFFMASTER3KCondition 2220NON-INTENSE REGIMENNICOTINE

Nicotine

0.1039mg/PUFF0.10390.1039mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL102-01-2023Week 01
11TOB07PT111PUFFMASTER3KCondition 2221NON-INTENSE REGIMENNICOTINENicotine0.1142mg/PUFF0.11420.1142mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL202-01-2023Week 01
12TOB07PT111PUFFMASTER3KCondition 2222NON-INTENSE REGIMENNICOTINENicotine0.1282mg/PUFF0.12820.1282mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL302-01-2023Week 01
13TOB07PT111PUFFMASTER3KCondition 2223NON-INTENSE REGIMENNICOTINENicotine0.1242mg/PUFF0.12420.1242mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL103-29-2023Week 82
14TOB07PT111PUFFMASTER3KCondition 2224NON-INTENSE REGIMENNICOTINENicotine0.1084mg/PUFF0.10840.1084mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL203-29-2023Week 82
15TOB07PT111PUFFMASTER3KCondition 2225NON-INTENSE REGIMENNICOTINENicotine0.1174mg/PUFF0.11740.1174mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL303-29-2023Week 82
16TOB07PT111PUFFMASTER3KCondition 2226NON-INTENSE REGIMENNICOTINENicotine0.1374mg/PUFF0.13740.1374mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL107-19-2023Week 243
17TOB07PT111PUFFMASTER3KCondition 2227NON-INTENSE REGIMENNICOTINENicotine0.1364mg/PUFF0.13640.1364mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL207-19-2023Week 243
18TOB07PT111PUFFMASTER3KCondition 2228NON-INTENSE REGIMENNICOTINENicotine0.1264mg/PUFF0.12640.1264mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL307-19-2023Week 243
19TOB07PT111PUFFMASTER3KCondition 2229NON-INTENSE REGIMENNICOTINENicotine0.1256mg/PUFF0.12560.1256mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL102-01-2023Week 01
20TOB07PT111PUFFMASTER3KCondition 3230NON-INTENSE REGIMENNICOTINENicotine0.1236mg/PUFF0.12360.1236mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL202-01-2023Week 01
21TOB07PT111PUFFMASTER3KCondition 3231NON-INTENSE REGIMENNICOTINENicotine0.1126mg/PUFF0.11260.1126mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL302-01-2023Week 01
22TOB07PT111PUFFMASTER3KCondition 3232NON-INTENSE REGIMENNICOTINENicotine0.1334mg/PUFF0.13340.1334mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL103-29-2023Week 82
23TOB07PT111PUFFMASTER3KCondition 3233NON-INTENSE REGIMENNICOTINENicotine0.1134mg/PUFF0.11340.1134mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL203-29-2023Week 82
24TOB07PT111PUFFMASTER3KCondition 3234NON-INTENSE REGIMENNICOTINENicotine0.1125mg/PUFF0.11250.1125mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL303-29-2023Week 82
25TOB07PT111PUFFMASTER3KCondition 3235NON-INTENSE REGIMENNICOTINENicotine0.1156mg/PUFF0.11560.1156mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL107-19-2023Week 243
26TOB07PT111PUFFMASTER3KCondition 3236NON-INTENSE REGIMENNICOTINENicotine0.1145mg/PUFF0.11450.1145mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL207-19-2023Week 243
27TOB07PT111PUFFMASTER3KCondition 3237NON-INTENSE REGIMENNICOTINENicotine0.1157mg/PUFF0.11570.1157mg/puffTPT LABCOTLAE01_v2.1.pdfAEROSOL307-19-2023Week 243

Details of the storage conditions are represented in the ES dataset. The variable STOCONID/Storage Condition ID represents the storage condition and links to the PT datasets by matching values of STOCONID there. Each of the parameters defining that storage condition are represented in ESPARMCD/ESPARM, with values and units shown in ESVAL/ESVALU. The ES dataset shows all 3 sets of storage conditions used across both of the PT dataset examples.

Dataset wrap
Namees
Dataset2
RowSTUDYIDDOMAINSTOCONIDESSEQESPARMCDESPARMESVALESVALU
1

TOB07

ESCondition 11HUMIDHumidity37%
2

TOB07

ESCondition 12TEMPTemperature24C
3

TOB07

ESCondition 21HUMIDHumidity60%
4

TOB07

ESCondition 22TEMPTemperature27C
5

TOB07

ESCondition 31HUMIDHumidity95%
6

TOB07

ESCondition 32TEMPTemperature31C
Dataset wrap
Namept
9
Rowcaps
Rows 1-9:Show the PTTEST of Nicotine for E-Liquid Standard (Long Term) Condition which is shown in PTTSTCND. The sample of various timepoints that may be used in the testing for Nicotine is reflected in PTTPT. The PTTPTNUM shows the numerical version of the planned timepoint.  The REPNUM shows the incidence number of a test that is repeated within a given timeframe for the same test.
Rows 10-18:Show the PTTEST of Nicotine for E-Liquid Accelerated Aging Condition across the same timepoints.  The PTGRPID is used to tie together a block of related records in a single domain.
Rows 19-28:Show the PTTEST of Nicotine for E-Vapor Standard Aerosol Condition across the same timepoints.  The PTGRPID is used to tie together a block of related records in a single domain.
Rows 29-36:Show the PTTEST of Nicotine for E-Vapor Intense Aerosol Condition across the same timepoints.  The PTGRPID is used to tie together a block of related records in a single domain.
Dataset2
Row

STUDYID

DOMAINPTSEQPTREFIDPTGRPIDPTTESTCDPTTESTPTTSTCNDPTORRESPTORRESUPTSTRESCPTSTRESNPTSTRESUPTSPECPTSPCCNDPTMETHODPTREPNUMPTTPTPTTPTNUM
1TOB07PT211VAP77777.11NIC

Nicotine

E-Liquid Standard (Long Term) Condition%%E-LIQUID1Week 012TOB07PT212VAP77777.11

NIC

NicotineE-Liquid Standard (Long Term) Condition%%E-LIQUID2Week 013TOB07PT213VAP77777.11NICNicotineE-Liquid Standard (Long Term) Condition%%E-LIQUID3Week 014TOB07PT214VAP77777.11NICNicotineE-Liquid Standard (Long Term) Condition%%E-LIQUID1Week 845TOB07PT215VAP77777.11NICNicotineE-Liquid Standard (Long Term) Condition%%E-LIQUID2Week 846TOB07PT216VAP77777.11NICNicotineE-Liquid Standard (Long Term) Condition%%E-LIQUID3Week 847TOB07PT217VAP77777.11NICNicotineE-Liquid Standard (Long Term) Condition%%E-LIQUID1Week 4898TOB07PT218VAP77777.11NICNicotineE-Liquid Standard (Long Term) Condition%%E-LIQUID2Week 4899TOB07PT219VAP77777.11NICNicotineE-Liquid Standard (Long Term) Condition%%E-LIQUID3Week 48910TOB07PT220VAP77777.12NICNicotineE-Liquid Accelerated Aging Condition%%E-LIQUID1Week 0111TOB07PT221VAP77777.12NICNicotineE-Liquid Accelerated Aging Condition%%E-LIQUID2Week 0112TOB07PT222VAP77777.12NICNicotineE-Liquid Accelerated Aging Condition%%E-LIQUID3Week 0113TOB07PT223VAP77777.12NICNicotineE-Liquid Accelerated Aging Condition%%E-LIQUID1Week 8414TOB07PT224VAP77777.12NICNicotineE-Liquid Accelerated Aging Condition%%E-LIQUID2Week 8415TOB07PT225VAP77777.12NICNicotineE-Liquid Accelerated Aging Condition%%E-LIQUID3Week 8416TOB07PT226VAP77777.12NICNicotineE-Liquid Accelerated Aging Condition%%E-LIQUID1Week 48917TOB07PT227VAP77777.12NICNicotineE-Liquid Accelerated Aging Condition%%E-LIQUID2Week 48918TOB07PT228VAP77777.12NICNicotineE-Liquid Accelerated Aging Condition%%E-LIQUID3Week 48919TOB07PT229VAP77777.13NIC

Nicotine

E-Vapor Standard Aerosol Condition%%E-LIQUID1Week 0120TOB07PT230VAP77777.13NICNicotineE-Vapor Standard Aerosol Condition%%E-LIQUID2Week 0121TOB07PT231VAP77777.13NICNicotineE-Vapor Standard Aerosol Condition%%E-LIQUID3Week 0122TOB07PT232VAP77777.13NICNicotineE-Vapor Standard Aerosol Condition%%E-LIQUID1Week 8423TOB07PT233VAP77777.13NICNicotineE-Vapor Standard Aerosol Condition%%E-LIQUID2Week 8424TOB07PT234VAP77777.13NICNicotineE-Vapor Standard Aerosol Condition%%E-LIQUID3Week 8425TOB07PT235VAP77777.13NICNicotineE-Vapor Standard Aerosol Condition%%E-LIQUID1Week 48926TOB07PT236VAP77777.13NICNicotineE-Vapor Standard Aerosol Condition%%E-LIQUID2Week 48927TOB07PT237VAP77777.13NICNicotineE-Vapor Standard Aerosol Condition%%E-LIQUID3Week 48928TOB07PT238VAP77777.13NICNicotineE-Vapor Standard Aerosol Condition%%E-LIQUID1Week 0129TOB07PT239VAP77777.14NICNicotineE-Vapor Intense Aerosol Condition%%E-LIQUID2Week 0130TOB07PT240VAP77777.14NICNicotineE-Vapor Intense Aerosol Condition%%E-LIQUID3Week 0131TOB07PT241VAP77777.14NICNicotineE-Vapor Intense Aerosol Condition%%E-LIQUID1Week 8432TOB07PT242VAP77777.14NICNicotineE-Vapor Intense Aerosol Condition%%E-LIQUID2Week 8433TOB07PT243VAP77777.14NICNicotineE-Vapor Intense Aerosol Condition%%E-LIQUID3Week 8434TOB07PT244VAP77777.14NICNicotineE-Vapor Intense Aerosol Condition%%E-LIQUID1Week 48935TOB07PT245VAP77777.14NICNicotineE-Vapor Intense Aerosol Condition%%E-LIQUID2Week 48936TOB07PT246VAP77777.14NICNicotineE-Vapor Intense Aerosol Condition%%E-LIQUID3Week 48